The epidermal growth factor receptor and androgen receptor (AR) both play major roles in the control of prostate growth. Our hypothesis is that shared downstream components of these two signaling pathways are significant participants in androgen-independent growth. Our first objective was to identify proteins whose activation and/or expression in AR-positive prostate epithelial cells are induced by both epidermal growth factor (EGF) and dihydrotestosterone (DHT). AR expression was induced in a tumorigenic, metastatic subline of the SV40 large Tantigen immortalized human prostate epithelial subline M12 by stable transfection with human wild-type AR cDNA. These M12AR ( þ ) cells with functional AR were treated in parallel with EGF (10 ng/ml) or DHT (10
for 24 h before 2D gel electrophoresis and Western immunoblotting with antiphosphotyrosine monoclonal antibody. Coomassie blue-stained spots on a 2D gel run in parallel were aligned with the phosphoproteins on the Western immunoblot, and identified by matrix-assisted laser desorption ionization/time-of-flight mass spectroscopy. The most interesting of the seven proteins that appeared to be phosphorylated by these criteria was 14-3-3 protein sigma. Protein extracted after either EGF or DHT treatment, immunoprecipitated with antiphosphotyrosine monoclonal antibody, and immunoblotted by anti-14-3-3 sigma confirmed phosphorylation of 14-3-3 sigma. Addition of either DHT or EGF to the M12AR( þ ) cells induced subcellular migration of 14-3-3 sigma and activated a 14-3-3 sigma reporter construct. Immunohistochemical analysis revealed nuclear localization of 14-3-3 sigma in higher Gleason grade prostate cancers relative to benign glands. These findings implicate 14-3-3 sigma in the development of human prostate cancer cells and could provide a new target for intervention in prostate cancer.
Introduction
Although prostate cancers initially respond to androgen ablation therapy, they frequently recur in an androgenindependent state (Martel et al., 2003) . However, loss of the requirement for androgen is not due to loss of androgen receptor (AR) expression, as most prostate cancers retain expression of ARs (El Sheikh et al., 2003) . Similarly, AR mutation occurs in only a small number of cases, and research reports indicate that there is a strong selective pressure to maintain AR activity after androgen ablation therapy (Balk, 2002) . Consideration of these findings has led many investigators to conclude that the survival and proliferation of androgen-independent prostate cancers require the involvement of additional growth-controlling pathways. In particular, these observations suggested that there is crosstalk between the AR signaling pathway and peptide growth factor receptor pathways. If so, the interaction of the two pathways may be crucial for the survival of these prostate cancer cells.
Evidence of crosstalk between the AR and the epidermal growth factor receptor (EGFR) in prostate cancer, defined as the ability of portions of one pathway to activate or modulate components of the other signaling pathway, is abundant (El Sheikh et al., 2003) . Transient transfections suggest that the insulinlike growth factor 1 (IGF1), and to a lesser extent EGF, can activate the AR promoter (Culig et al., 1994) . Other mechanisms that are documented include androgenmediated upregulation of the EGFR itself (Myers et al., 1999; Torring et al., 2003) , activation of the mitogenactivated protein kinase (MAPK) pathway by androgen-activated AR (Peterziel et al., 1999) , enhancement of AR transcriptional activity by peptide growth factors (Orio et al., 2002) , and interactions between the mitogen-activated protein kinase/extracellular signalregulated kinase kinase kinase-1 (MEKK1) and the AR (Abreu-Martin et al., 1999).
Our objective was to apply a proteomic approach to identify proteins that were phosphorylated in AR expressing prostate epithelial cells in the presence of either dihydrotestosterone (DHT) or EGF. Because our objective was not simply to identify those proteins induced in common, but rather to recognize proteins active in these signaling pathways, we chose to apply 2D gel electrophoresis, Western immunoblotting with antiphosphotyrosine antibodies, and mass spectroscopy to identify those proteins that were phosphorylated after exposure of the AR-positive prostate cells M12AR( þ ) to either DHT or EGF. We identified 14-3-3 sigma as a potential phosphorylation target in AR-positive cells for both pathways. Furthermore, 14-3-3 sigma migrated from the cytoplasm into the nucleus of M12AR( þ ) cells in response to either DHT or EGF. Nuclear localization was observed significantly more often among prostate cells in malignant glands of higher Gleason grades, as compared to benign glands in clinical specimens.
This is the first demonstration that 14-3-3 sigma may be one of the mediators of common signaling events between AR and EGFR in human prostate cancer cells. Given the importance of this protein in the regulation of apoptosis, proliferation, and cell cycle control (van Hemert et al., 2001) , this suggests that 14-3-3 sigma could provide a new target for intervention in prostate cancer.
Results

Effect of DHT and EGF on M12AR ( þ ) cells
The Coomassie blue-stained two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) profile of the AR-positive M12 cells (M12AR( þ )) 24 h after stimulation by either DHT (Figure 1a ) or EGF ( Figure 1c ) revealed approximately 1200 Coomassie blue staining spots. As illustrated in Figure 1b and d, 20 of these spots also reacted with the antiphosphotyrosine antibody, 24 h after the addition of either DHT or EGF. Seven spots reactive with the antiphosphotyrosine antibody were present in both the EGF-and the DHT-stimulated M12AR( þ ) cells. These proteins, identified by matrixassisted laser desorption ionization/time-of-flight mass spectroscopy (MALDI-TOF MS), are listed with their associated characteristics in Table 1a and b. In contrast, control cells not exposed to either EGF or DHT did not display any spots reactive with the antiphosphotyrosine antibody (Figure 1e and f). The spectrum of the tryptic peptides extracted from the DHT-stimulated M12AR( þ ) cells and identified as 14-3-3 sigma is shown in Figure 2 . Independent verification that 14-3-3 sigma was phosphorylated after exposure to either EGF or DHT was obtained when the treated cells were immunoprecipitated with antiphosphotyrosine antibody, followed by immunoblot analysis with anti-14-3-3 sigma antibody. As shown in Figure 3 , protein immunoprecipitated with antiphosphotyrosine from cells exposed to either EGF or DHT was reactive with anti-14-3-3 sigma monoclonal antibody immunoblots, while that from nontreated controls remained negative. Given the importance of 14-3-3 sigma in cell cycle regulation and apoptosis, our subsequent analysis focused on this protein.
14-3-3 sigma protein induction by DHT and EGF in AR( þ ) and AR(À) cells The 14-3-3 sigma protein level itself increased after exposure to EGF or DHT. The magnitude of the 14-3-3 sigma response to EGF differed between the AR- Figure 2 Spectrum of tryptic peptides extracted from spot D3 aligned between Coomassie blue-stained 2D-PAGE and immunoblot of extract from M12AR( þ ) cells 24 h after addition of DHT. Major monoisotopic peaks of trypsin-digested peptides, detected by MALDI-TOF MS, are indicated on the spectrum. The sequence of 14-3-3 sigma is displayed in the upper right corner, where peptide matches between the sample analysed by MALDI-TOF MS and the 14-3-3 sigma sequence are shown italic bold
14-3-3 sigma tyrosine-phosphorylation detected by Immunoprecipitation and immunoblot
Blot:
Anti-1433 sigma Ab Figure 3 Total cellular lysates (500 mg) of M12AR( þ ) and AR(À) cells at 24 hours after stimulation with EGF (10 mg/ml) or DHT (10 À8 M), or neither (control) were immunoprecipitated with antibody of anti-phosphotyrosine and then immunoblotted with the anti-14-3-3 sigma Ab 14-3-3 sigma and prostate cancer D Huang et al positive and AR-negative M12 cells. The level of the 14-3-3 sigma protein increased 3 h after exposure to EGF and 6 h after DHT exposure in the M12AR( þ ) cells, plateaued at 12 h, and remained high at 24 h ( Figure 4 ). In contrast, in the AR-negative M12 cells, the level of 14-3-3 sigma modestly increased at 12 and 24 h after EGF exposure, but did not reach the same level as in the M12AR( þ ) cells. A minimal level of 14-3-3 sigma protein was detectable at all time points in the M12AR(À) cells under all conditions, which we interpreted as a basal level of expression.
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Effect of DHT and EGF on 14-3-3 sigma promoter activity
The activity of a 14-3-3 sigma reporter construct transiently transfected into M12AR( þ ) cells was significantly induced by exposure to either DHT or EGF ( Figure 5 ). The largest increase was seen 24 h after stimulation with both agents. As expected, the ARnegative M12 cells did not display a significant response to DHT (i.e., the activity of the reporter construct was not significantly different from the control without EGF Both DHT and EGF increased expression of 14-3-3 sigma protein in M12AR( þ ) cells. Cell lysates were prepared and subjected to western blot with anti-14-3-3 mAb. the densitometic measurement was also shown in the figure Figure 5 Activation of 14-3-3 sigma promoter in M12AR( þ ) or M12AR(À) cells with exposure to DHT or EGF or neither (control). Activation of the 14-3-3 sigma promoter was detected with the promoter-luciferase construct. Cells were treated as described in Materials and methods and stimulated for the time course indicated. The data represent mean values þ s.d. of three independent experiments (*Po0.01) (Student's t-test, paired)
14-3-3 sigma and prostate cancer D Huang et al or DHT). An increase in promoter induction occurred in these cells after EGF exposure, but the magnitude was much less than in the AR-positive M12 cells.
Translocation of GFP-14-3-3 sigma to the nucleus Exposure of M12AR( þ ) cells to either DHT or EGF resulted in a significant increase in the translocation of GFP-fused 14-3-3 sigma into the nucleus of these cells, as compared to cells that were not exposed (Po0.01) ( Figure 6 ). In contrast, although EGF induced nuclear translocation of the GFP-14-3-3 sigma in the M12AR(À) cells, no significant movement of GFP-14-3-3 sigma occurred after DHT addition, as expected ( Figure 6 ). When AR-positive M12 cells were simultaneously exposed to EGF and DHT, the percentage of cells displaying nuclear GFP-14-3-3 sigma was significantly greater than addition of EGF or DHT alone ( Figure 6 ). Representative photographs of nuclear and cytoplasmic transfection by GFP-14-3-3 sigma are provided in Figure 7 .
Expression of 14-3-3 sigma in clinical prostate samples
Analysis of reactivity with a monoclonal antibody recognizing 14-3-3 sigma indicated that benign and malignant prostate cancers displayed significantly different patterns of expression of this protein. As shown in Table 2 , malignant glands with Gleason scores of 6 or greater reacted positively with anti-14-3-3 sigma antibody in the nucleus significantly more often than in benign glands, whereas the benign glands and welldifferentiated prostate cancers (Gleason score of 5 or less) displayed 14-3-3 sigma in the cytoplasm, but no significant nuclear staining in the nucleus. Nuclear staining in prostate carcinoma (Figure 8b and d) and cytoplasmic staining in benign cells (Figure 8a and c) are illustrated. Note that only the 2 þ to 3 þ staining was counted as positive. All of the prostate tissue samples expressed ARs, as assessed by immunohistochemical staining with anti-AR antibody N20 (recognizing the amino terminus of the AR) and anti-AR C19 (recognizing the carboxy terminus of the AR). 
Discussion
These results support the concept that 14-3-3 sigma is an important downstream component of signaling in ARpositive prostate epithelial cells induced by either EGF or androgen. Exposure of the AR-positive M12 human prostate epithelial cells to either EGF or DHT increases expression of the 14-3-3 sigma protein, results in phosphorylation of 14-3-3 sigma, and stimulates translocation of 14-3-3 sigma into the nucleus.
The increased expression of the 14-3-3 sigma protein is consistent with our previous demonstration that 14-3-3 sigma transcript expression is increased by exposure of these cells to DHT or EGF, as measured in gene expression microarrays and RT-PCR (York et al., submitted). In the present report we show that this increased transcription could occur by a direct mechanism, as treatment of AR-positive cells with either DHT or EGF significantly increases the activity of a 14-3-3 sigma reporter construct in transient transfection assays, but only EGF directly activates the promoter in ARnegative cells (as one would expect from a mechanism that requires participation of the AR as well as the ligand). This result is consistent with the failure to detect significant increases in 14-3-3 protein in response to DHT in AR-negative M12 cells (Figure 4) .
Both shared and independent EGF and AR signaling pathways appear to be involved in different aspects of the 14-3-3 sigma response. Nuclear translocation of GFP-14-3-3 sigma was significantly greater in the presence of DHT and EGF added simultaneously, as compared to either alone, in the AR-positive cells. The AR-negative cells did not display additive behavior. This would be consistent with separate pathways mediating nuclear translocation induced by EGF and DHT. Yet, as noted previously, activation of the 14-3-3 sigma promoter and increased production of 14-3-3 sigma protein require participation of the AR. The finding of phosphorylation of 14-3-3 sigma in ARnegative cells exposed to DHT (Figure 3) suggests a non-AR-mediated androgen induction of phosphorylation of the 14-3-3 sigma within the cytoplasm. Clearly, complex mechanisms mediate this protein's functions.
Extensive investigation in other laboratories has established that 14-3-3 proteins play multiple, critical roles in the control of cell proliferation and apoptosis (Subramanian et al., 2001; Tzivion and Avruch, 2002; Laronga et al., 2000) . There are seven isoforms of 14-3-3 expressed in humans, which appear to exert different effects in cells depending on cell type-specific isoform expression, subcellular location, and differential target specificity (Tzivion and Avruch, 2002) . The 14-3-3 sigma protein is the predominant isoform expressed in epithelial cells (Yaffe, 2002) and can bind to several steroid hormone receptors, including the AR (Zilliacus et al., 2001) . Cotransfection of a different 14-3-3 isoform, 14-3-3-eta, enhances AR dependent stimulation of a luciferase reporter construct, but the mechanism remains unknown (Haendler et al., 2001) .
However, despite the importance of this protein in cell death and survival, the role of 14-3-3 sigma in prostate cancer is unknown. In breast cancer, expression of 14-3- 14-3-3 sigma and prostate cancer D Huang et al 3 sigma is significantly decreased in malignant tissue (Vercoutter-Edouart et al., 2001) , often due to methylation of the 14-3-3 sigma gene (Ferguson et al., 2000; Osada et al., 2002) . Immunohistochemical staining of our prostate tissue microarrays with anti-14-3-3 sigma antibody demonstrated mild staining ( þ 1 intensity) in the cytoplasm of most, but not all, benign and malignant prostate epithelial cells. However, in terms of strong ( þ 2, þ 3) reactivity with the anti-14-3-3 sigma, significantly more reactivity was detected within the nucleus of the malignant prostates as compared to benign glands (Table 2 ; Figure 8b and d). Nuclear reactivity was rarely seen in benign glands, which generally displayed strong reactivity only in the cytoplasm (Table 2 ; Figure 8a and c). This result suggests that the subcellular distribution of 14-3-3 sigma may be altered in prostate tumors as they progress. The 14-3-3 proteins can shuttle between the nucleus and the cytoplasm, providing a means of sequestering 14-3-3 bound proteins (Brunet et al., 2002; Chan et al., 1999) . Given our demonstration of greater nuclear translocation after exposure to DHT or EGF in the M12AR( þ ) cell line (Figure 6 ), the patterns detected in our immunohistochemical study may reflect quantitative variations in the level of androgen and/or growth factors present in different individuals. Additional analyses will be required to resolve this issue. The use of a combination of 2D-PAGE, MALDI-TOF mass spectrometry, and Western immunoblot led to our recognition that 14-3-3 sigma was among several proteins reactive with antiphosphotyrosine monoclonal antibody after exposure to DHT or EGF (Figures 1 and  2 ; Table 1 ). Obviously, use of whole-cell extracts and 2D-PAGE does preferentially detect more abundant proteins (Gygi et al., 2000) , and there are certainly other proteins phosphorylated after exposure of cells to these agents. Nonetheless, we believe that our choice of this type of approach, with the implicit interpretation that proteins phosphorylated after exposure to a potential growth regulator are more likely to participate in a biologically significant activity, provided a productive method to simplify a complex proteomic analysis.
Clearly, 14-3-3 sigma is a key mediator of diverse cellular processes. Our investigation supports the concept that it could provide a critical common component of signaling by either androgen or peptide growth factors like EGF, and thus may contribute to the growth of androgen-independent prostate cancer cells. If further analyses support this interpretation, 14-3-3 sigma could provide a new target for intervention in prostate cancer.
Materials and methods
Human prostate epithelial cell lines
The creation, characterization, and growth conditions for the SV40 large T-antigen immortalized human prostate epithelial cell line P69SV40Tag and its sublines, including M12, have been detailed previously (Bae et al., 1994 (Bae et al., , 1998 . Nonneoplastic prostate epithelial cells were immortalized by transfection with SV40 T-antigen DNA (Bae et al., 1994) . Serial passage of sublines of these cells in athymic nude mice led to isolation of the M12 subline, which is consistently tumorigenic and metastatic after orthotopic injection, although AR negative (Bae et al., 1998) .
The AR-expressing M12 cells were created by stable transfection with a CMV 3.1 expression vector containing the cDNA encoding the full-length wild-type AR, and clones expressing the AR were isolated and characterized as described elsewhere (Plymate et al., 2004) .
Protein extraction and 2D-PAGE
Prior to protein extraction, cells were cultured in RPMI 1640 without serum or added growth factors for 24 h in a humidified 5% CO 2 incubator. Then, fresh RPMI 1640 containing either EGF (10 ng/ml) or DHT (10 À8 M) was added to the cultures, as indicated, and cultured for 24 h prior to harvest. Controls received only fresh RPMI 1640 without either EGF or DHT.
To extract proteins, cells grown in 100 mm tissue culture plates to 80% confluence were washed twice with cold phosphate-buffered saline (PBS) and 100 ml of ReadyPrep sequential extraction reagent 2 (Bio-Rad, CA, USA) containing 8 M urea, 4% CHAPS, 2 mM TBP, 40 mM Tris, 0.2% BioLyte ampholytes, protease inhibitors and endonuclease were added to each culture plate. Cells were scraped, centrifuged at 12 000 g for 10 min at 41C, and DNA was sheared by aspiration with a 27-gauge needle. The soluble proteins were recovered, aliquoted, and stored at À801C until use. Protein concentration was determined using the Bio-Rad Protein Assay (Bio-Rad, CA, USA).
Total cell lysates were subjected to 2D-PAGE separation. First-dimension isoelectrophoresis was performed with ReadyStrip immobilized pH gradient (IPG) strips (pH 3-10 nonlinear gradient, 11 cm; Bio-Rad, CA, USA). IPG strips were firstly rehydrated overnight in 200 ml rehydration buffer (BioRad, CA, USA) containing 8 M urea, 2% CHAPS, 50 mM DTT, 0.2% Bio-Lyte ampholytes, and a trace of bromophenol blue. After rehydration, 1 mg of total protein was mixed with sample buffer containing 8 M urea, 2% CHAPS, 50 mM DTT, 0.2% Bio-Lyte ampholyte, and a trace of bromophenol blue, to a total volume of 180 ml. The mixture was pipetted into IPG strip holder channels. Isoelectric focusing was conducted automatically in the Bio-Rad Protean IEF cell as follows: linear 250 V for 20 min, linear 8000 V for 150 min, rapid 8000 V for VH 60 000. After the IEF, strips were equilibrated in the Bio-Rad equilibration buffer I (375 mM Tris-HCl pH 8.8, 6 M urea, 2.0% SDS, 20% glycerol, and 130 mM DTT) for 15 min and then in the Bio-Rad equilibration buffer II (375 mM TrisHCl pH 8.8, 6 M urea, 2.0% SDS, 20% glycerol, and 135 mM iodoacetamide) for 15 min. Equilibrated strips were placed on top of a 13.3 Â 8.7 cm 4-20% SDS-PAGE gel, and the seconddimension separation was performed for 1 h at 200 V. After electrophoresis, the gels were stained in Bio-Safe Coomassie Blue (Bio-Rad, CA, USA) and then destained with water. Scanning and image analysis of the resulting 2D-PAGE was performed on a BioRad Densitometer GS710 and analysed with PDQuest Software Version 7.0 (Bio-Rad, CA, USA) as described previously (Liu et al., 2003) .
Phosphoprotein identification by MALDI-TOF
After separation by 2D-PAGE, proteins were transferred to a PVDF membrane (Amersham Life Science, USA), which was then blocked with 5% milk containing TBS-T buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05% , and incubated with a 1 : 1000 dilution of antiphosphotyrosine monoclonal antibody (Upstate Biotech, NY, USA) for 2 h at 231C. Blots were washed three times (15 min each) in TBST-T 14-3-3 sigma and prostate cancer D Huang et al and then incubated with a 1 : 2000 dilution of horseradish peroxidase-conjugated secondary antibodies for 1 h at 231C. Blots were again washed three times (15 min each) in TBST-T and then developed by enhanced chemiluminescence (Amersham, USA). Spots on a Coomassie blue-stained 2D gel run in parallel with each gel transferred by immunoblotting in each set were aligned with the spots on the phosphoprotein immunoblot films. Those matched spots were cut out from the gels and washed with water. The gel pieces were destained, reduced in DTT, and alkylated in iodoacetamide solution. Proteins were digested with sequencing grade trypsin (Promega, USA) overnight at 371C. MALDI-TOF analysis of trypsin digests was performed on a Micromass R (MicroMass, UK) reflector time-of-flight mass spectrometer (MS). Each sample (0.5 ml of sample, representing about 5% of the total digest volume) was mixed with 0.5 ml of the matrix (alpha-cyano-4-hydroxy-trans-cinnamic acid, 10 mg/ml in 50% acetonitrile/ 0.1% TFA), spotted onto the MS plate and air-dried. Samples were analysed by MALDI-TOF operated in the delayed extraction/reflectron/positive ion detection mode with an accelerating voltage of 15 kV and 499 ns delay. A nitrogen laser (377 nm) was used to irradiate the sample and spectra were acquired in the mass range 800-3000 Da. Protein sequence database searching was performed on the SWISS-PROT database using ProteinLynx Global Server 1.1 and Micromass proteinLynx software. The following general search parameters were used: monoisotopic molecular masses, enzyme specificity trypsin, all species allowed, variable methionine oxidation and carbamidomethylcysteine alkylation, one missed cleavage for trypsin digests, and a mass tolerance of 80 ppm. A positive identification in the peptide match fingerprint required a minimum of 30% coverage, at least 10 matched peptides, and a positive score in analyses of multiple samples from each given digest.
Western immunoblotting
M12AR( þ ) and M12AR(À) cells were treated with EGF (10 ng/ml) and DHT (10 À8 M) for 0, 3, 6, 12, and 24 h. Total cell lysates were collected and subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane (Amersham Life Science, USA), blocked with 5% milk containing TBS-T buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05% Tween-20), and incubated with 1 : 1000 dilution of anti-14-3-3 antibodies (Research Diagnostics Inc., NJ, USA) for 2 h at 231C. Blots were washed three times (15 min each) in TBST-T and then incubated with a 1 : 2000 dilution of horseradish peroxidaseconjugated secondary antibodies for 1 h at 231C. Blots were again washed three times (15 min each) in TBST-T and then developed by enhanced chemiluminescence (Amersham, USA). To monitor equal sample loading, the same volume of protein was probed with anti-actin antibodies (Santa Cruz, USA).
Immunoprecipitation with anti-14-3-3 sigma and immunoblot analysis Cells were cultured in 100 mm plates until 80-90% confluent. The cells were then incubated in serum-free medium overnight, and then treated with EGF (10 ng/ml) or DHT (10 À8 M). For immunoprecipitation and Western blot analysis, cells were lysed using modified RIPA buffer: 50 mM Tris-HCl, pH 7.4; 1% NP-40; 0.25% sodium deoxycholate; 150 mM NaCl; 1 mM EDTA; 1 mM PMSF; 1 mg/ml aprotinin, leupeptin, pepstatin; 1 mM Na 3 VO 4 ; 1 mM NaF. The lysates were centrifuged for 15 min at 14 000 rpm in a microcentrifuge. Protein content of the resultant supernatants was measured by the Bio-Rad protein assay. The protein concentration was adjusted to 1 mg/ ml with PBS. Stimulated cell lysate, as well as unstimulated lysate (500 mg each), was then incubated overnight at 41C with 2 mg of antiphosphotyrosine monoclonal antibody (recombinant 4G10, agarose conjugate) (Upstate Biotech, NY, USA). Immunoprecipitates were resolved on 10% sodium dodecyl sulfate-polyacrylamide gel and electroblotted to nitrocellulose membrane. The membranes were blocked for 1 h at room temperature in 5% nonfat dry milk in 1 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween-20 (TTBS), and probed with mouse antibody to 14-3-3 sigma (1 : 500) for 2 h at room temperature. The membranes were then washed three times with TTBS, incubated with horseradish peroxidase-labeled secondary anti-mouse IgG (1 : 1000) in 5% nonfat dry milk in TTBS, washed three times in TTBS, and then developed with ECL reagent (Amersham, USA).
Luciferase reporter assay
The 14-3-3 sigma promoter cloned upstream of the luciferase gene (Hermeking et al., 1997) was kindly provided by Dr B Vogelstein (Johns Hopkins University). Cells were divided 24 h prior to the experiment into six-well plates and transfected with Lipofectamine (Life Technologies Inc., USA) at 70% confluence. Each transfection reaction contained 2 mg of 14-3-3 promoter-luciferase reporter vector DNA and 0.05 mg of pRL-SV40 vector as a transfection control. After 48 h, cells were washed with PBS, scraped into 500 ml of 1 Â Passive Lysis Buffer, and incubated at room temperature for 30 min to ensure complete lysis. Cellular lysates were cleared by centrifugation and 20 ml of lysate was combined with 100 ml of Luciferase Assay Reagent II in a luminometer tube and immediately analysed on the TD-20/20 luminometer (Turner Designs, Sunnyvale, CA, USA). The ratio between firefly luciferase activity and Renilla luciferase activity was calculated and displayed on the screen when the dual assay mode was performed. Cells that were transfected with a pGL3 basic luciferase report vector lacking 14-3-3 promoter cDNA served as a nonspecific control. The experiments in each figure were repeated at least three times.
Detection of subcellular localization of GFP-fused 14-3-3s
The GFP-fused 14-3-3s plasmid (Kino et al., 2003) was kindly provided by Dr T Kino (NIH, Bethesda, MD, USA). Transient transfection was performed using lipofectin (Life Technologies, Rockville, MD, USA), according to the manufacturer's protocol. Briefly, cells were plated in six-well plates in 5% FBS containing media and grown to 80% confluence. To each well, 2 mg of GFP-fused 14-3-3s plasmid and 10 ml of lipofectin reagent were added in the presence of optimal reduced serum media (Life Technologies, Rockville, MD, USA). After 24 h, this medium was replaced with 5% charcoal/dextran-treated fetal bovine serum with antibiotics. The cells were analysed 48 h after transfection. Using an inverted fluorescence microscope (Olympus Co, Japan), images were captured with a digital camera. To examine the subcellular distribution of GFP-14-3-3s, numbers of cells exhibiting two different distribution patterns from cytoplasmic to nuclear localization were counted and percentages of each fraction to the total transfected cell number were calculated, and a total of 300 cells were evaluated at each time point.
Construction of prostate tissue microarrays
Archival formalin-fixed paraffin-embedded prostate tissues collected at the Virginia Commonwealth University Health System during 1991-2001 provided the source material.
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Hematoxylin-and eosin-stained sections of each block were used to identify benign glands and prostate adenocarcinomas ranging from combined Gleason scores of o6, 6-8, and 48. Using a Tissue Microarray (TMA) precision instrument manufactured by Beecher Instruments, recipient wells with a diameter of 1 inch were punched into the recipient paraffin blocks and filled with a 1-inch-diameter punch of the selected tissue. Each case was represented in triplicate on the TMA blocks. A total of 23 benign samples and 67 prostate cancers were included.
Immunohistochemical staining of prostate TMAs
Sections 4 mm thick were cut from each TMA block, deparaffinized and reacted with monoclonal anti-14-3-3 sigma (RDI, USA) at a concentration of 5 mg/ml for 1.5 h at room temperature. Antibody binding was detected with the VectaStain ABC mouse kit (Vector Laboratories, USA) following the manufacturer's protocol and reactivity was detected with DAB.
Reactivity with the antibody in each case was assigned an intensity of 0, 1 þ , 2 þ , or 3 þ , and the percentage of cells expressing that intensity was estimated by the participating pathologist. Both nuclear and cytoplasmic reactivities were evaluated and scored separately.
Statistical analysis
Expression of 14-3-3 sigma among benign and malignant prostate cases was evaluated by logistic regression analysis. A P-value less than 0.05 was considered statistically significant.
